Gitnux/Report 2026

Global Medical Device Industry Statistics

The global medical device market is forecast to reach $570.0 billion in 2026, explore the figures behind growth, company financials, and 2026 trends.
32Statistics
31Sources
5Sections
1Visuals
17mRead
Global Medical Device Industry Statistics
How this report is researched
01Editorial Scope

An editor sets the topic, the inclusion criteria, and the evaluation framework before research starts.

02Source Research

AI search agents locate sources and extract each figure together with the document it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 32 days

01 Industry overview

The global medical device industry at a glance

The global medical device market is estimated at $570.0 billion in 2026, following a projected 5.5% increase from $540.3 billion in 2025, with growth centered on connected, minimally invasive and AI-enabled technologies.

$570.0B[4]
Global market, 2026 estimate
6.2%[4]
Forecast CAGR, 2025–2030
35.2%[4]
North America share, 2025
950,000+[19]
European medtech jobs, 2025
Market size
The global medical device market was valued at $540.3 billion in 2025 and is forecast to reach $570.0 billion in 2026. A separate Frost & Sullivan industry report estimates the market at $623.0 billion in 2024, illustrating how market totals vary by scope and methodology.[4][3]
Forecast & CAGR
The market is forecast to expand at a 6.2% compound annual growth rate from 2025 to 2030, reaching $729.8 billion by 2030. Another Frost & Sullivan estimate projects $869.7 billion by 2030 and a 6.0% CAGR for 2025–2030, reflecting different market definitions.[4][3]
Market share & regions
North America accounted for about 35.2% of global medical device revenue in 2025, followed by Europe at 26.2% and Asia-Pacific at 23.0%. Their estimated 2025 market values were $190.2 billion, $141.6 billion and $124.3 billion, respectively.[4]
Segmentation
Cardiovascular devices were the largest named segment in 2025, with a 12.5% share, followed by diagnostic imaging at 10.2% and orthopedics at 9.6%. Ophthalmology represented 8.4%, while drug delivery, endoscopy and diabetes care accounted for 6.9%, 6.3% and 6.0%, respectively.[4]
Key players & concentration
The industry remains fragmented in Europe: MedTech Europe reports more than 36,000 medical technology companies in 2025, with around 90% classified as small and medium-sized enterprises. The same source reports more than 950,000 direct jobs, indicating a broad supplier and manufacturing base rather than a market dominated only by a few firms.[19]
Trends, drivers & challenges
Growth is being supported by intelligent, connected and minimally invasive devices, as well as AI-assisted technologies that are reshaping diagnostic and therapeutic workflows. Industry pressure points include regulatory costs and the need to maintain competitiveness: MedTech Europe reports more than 15,900 European patent applications in 2025 and says 90% of European medtech companies are SMEs.[3][19]
Consumer behavior & competition
Medtech companies are expanding beyond hospitals into ambulatory surgery centers and direct-to-consumer or direct-to-patient channels. EY reported that global medtech M&A value increased 160% in the first half of 2026 compared with the first half of 2025, with investment focused on AI-enabled diagnostics, robotics, structural heart, diabetes care and minimally invasive therapies.[20]
M&A
M&A remained active in 2026: Abbott completed its $21 billion acquisition of Exact Sciences, while Boston Scientific announced a planned $14.5 billion acquisition of Penumbra. In outsourced manufacturing, KKR agreed to acquire Integer Holdings for approximately $5.7 billion and Teledyne agreed to buy Varex Imaging for about $1.1 billion.[21][22]
Regulation
The U.S. FDA’s Quality Management System Regulation took effect on February 2, 2026. It amended 21 CFR Part 820 and incorporated ISO 13485:2016 by reference, while the FDA also replaced its previous device inspection process with the updated Compliance Program 7382.850.[7][23]
Latest news
The most significant reported 2026 development was renewed large-scale consolidation: Abbott’s $21 billion Exact Sciences acquisition and Boston Scientific’s planned $14.5 billion Penumbra deal were identified among the year’s largest medtech transactions. EY also reported a 160% year-on-year increase in global medtech M&A value during the first half of 2026.[21][20]

02 Ranking

Top 10 Companies in the Global Medical Device Industry

The leading companies in the global medical device industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 21, 2026 · Next review December 21, 2026

Verdict

Boston Scientific stands out for interventional cardiovascular and MedSurg reach because it reported $20.1 billion in FY2025 sales across cardiovascular and MedSurg businesses, while Medtronic focuses on global healthcare technology since it reported FY2026 revenue of $36.4 billion.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in cardiovascular & interventional

    Boston Scientific

    US

    Ranked #1 · 9.4 · Cardiovascular & interventional

    Why we picked it: Interventional cardiovascular, endoscopy and urology devices for cardiovascular and MedSurg markets

  2. Leader in diagnostics, imaging & therapy

    Siemens Healthineers

    DE

    Ranked #3 · 9.1 · Diagnostics, imaging & therapy

    Why we picked it: Its imaging, diagnostics, cancer care, and minimally invasive therapy span manufacturing scale shown by 74,000 employees.

  3. Leader in surgical, endoscopy & vision

    Johnson & Johnson

    US

    Ranked #4 · 9.0 · Surgical, endoscopy & vision

    Why we picked it: Its MedTech work covers cardiovascular, orthopaedics, surgery, and vision devices with 15.6% of revenue in R&D.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 10 companies in the global medical device industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Boston Scientific

Cardiovascular & interventional · US

9.4
2

Medtronic

Cardiovascular & interventional · IE

9.1
3

Siemens Healthineers

Diagnostics, imaging & therapy · DE

9.1
4

Johnson & Johnson

Surgical, endoscopy & vision · US

9.0
5

Edwards Lifesciences

Structural heart & critical care · US

8.9
6

ResMed

Sleep apnea and connected respiratory devices · US

8.7
7

Olympus

Endoscopy and therapeutic medical systems · JP

8.6
8

Terumo

Interventional, cardiovascular, blood and infusion devices · JP

8.6
9

Align Technology

Clear aligners and digital orthodontic systems · US

8.2
10

Baxter International

Infusion, advanced surgery, monitoring and respiratory devices · US

7.5

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 21, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 21). Top 10 companies in the global medical device industry. In Global Medical Device Industry Statistics. Gitnux. https://gitnux.org/global-medical-device-industry-statistics/#top-companies

report visual · Comparison

Global medical device market size

Global medical device market size: $518.0B in 2024, $518.0B in 2024.

2029 (forecast)$667.4B
2028 (forecast)$634.4B
2027 (forecast)$603.1B
2026 (forecast)$573.3B
2025 (forecast)$544.9B
2024$518.0B
source-verifiedsebi.gov.in2029

04 Statistics

Technology

Medical technology appears in global patent activity as 4.6% of published patent applications worldwide in 2024, with 15,701 European filings in the same WIPO IPC-based classification.

R&D, patents and design rights in the global medical device industry

  • Medical technology accounted for 4.6% of published patent applications worldwide in 2024 under WIPO’s IPC-based technology-field classification.[1]
  • 182,367 published patent applications worldwide concerned medical technology in 2022, equal to 5.4% of all published applications; no newer complete global field measurement was available in the cited WIPO release.[1]
  • 15,701 European patent applications were filed in medical technology in 2024, under the WIPO IPC technology-field classification used by the EPO.[2]

05 Statistics

Market Intelligence

Market totals vary by scope: Frost & Sullivan estimates $623.0 billion for 2024, while another estimate places 2024 at $518.0 billion, both feeding forward to 2030 projections.

Market size, volume and shipments in the global medical device industry

  • $623.0 billion was the 2024 global medical device market, covering medical equipment, medical consumables and clinical-application segments, according to Frost & Sullivan.[3]
  • $518.0 billion was the 2024 global medical device market, covering the medical device industry as defined in Frost & Sullivan's market study.[4]

Forecast growth and shipments in the global medical device industry

  • The global medical device market is forecast to reach $869.7 billion in 2030, growing at a 6.0% CAGR from 2025 to 2030.[3]
  • The global medical devices market is forecast to grow by $227.3 billion at a 6.3% CAGR during 2025–2030.[5]
  • The global medical device market is forecast to reach $1,157.6 billion in 2035, growing at a 5.7% CAGR from 2031 to 2035.[3]

Company counts and size structure in the global medical device industry

  • 17,558 worldwide medical device companies employed at least 50 people, based on business-register data covering medical-device SIC codes in 188 countries.[6]
  • 29,178 medical device establishments were registered with the U.S. FDA in fiscal year 2025, covering establishments subject to FDA device-registration reporting rather than all global operators.[7]
  • 24,795 unique establishments were identified across 417,036 FDA device-listing records in a June 2026 extraction, mapping the global manufacturing footprint recorded in the FDA database.[8]

Regional split of the global medical device industry

  • North America generated approximately $190.2 billion, or 35.2% of the global medical device market, in 2025.[4]
  • Asia-Pacific generated approximately $124.3 billion, or 23.0% of the global medical device market, in 2025.[4]
  • North America held 38% of the global medical device market in 2024; the source defines the market geographically across North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.[9]
  • Europe held 27% of the global medical device market in 2024; the source defines the market geographically across five global regions.[9]

06 Statistics

Strategy & Growth

M&A and transaction volume remain high: global medtech M&A recorded 27 transactions worth $43.4 billion in upfront cash and equity in Q4 2025.

M&A and consolidation in the global medical device industry

  • Within the broader global medical-equipment, consumables and services category, financial investors accounted for 33% and industrial investors for 67% of fiscal-year 2025 transactions.[10]
  • The broader global medical-equipment, consumables and services category recorded 1,388 transactions in fiscal year 2025, up 9% year over year.[10]
  • Global medtech M&A recorded 27 transactions worth $43.4 billion in upfront cash and equity in Q4 2025; full-year disclosed deal value reached $44.6 billion.[11]
  • The median upfront cash and equity value of global medtech M&A transactions was $404 million in Q4 2025.[11]

07 Statistics

Pricing & Finance

Cost pressure shows up in raw materials and supply chains, with medical-device raw-material costs reported up 15–20% in 2024 and supply-chain costs reaching up to 20% of revenue.

Input costs in the global medical device industry

  • 15–20% was the reported 2024 increase in medical-device raw-material costs, particularly for plastics, resins and metals, amid inflationary pressure.[12]
  • Supply-chain costs reached up to 20% of revenue for medical-device manufacturers in 2024, increasing by 2–3 percentage points from 2022.[13]
  • 3–5% of revenue was allocated to supply-chain services by medical-device manufacturers in 2024.[13]

Margins and profitability in the global medical device industry

  • 26% was the average EBITDA margin for global lab and diagnostics companies in the first half of 2023, compared with 22% for surgical-instrument companies and 18% for medical-aids and-device companies.[14]
  • 22% was the median EBITA margin in 2024 for the top 30 global medtech companies, down from approximately 27% at its early-2021 peak; the analysis used quarterly company data through August 31, 2024.[15]
  • 27% was the 75th-percentile EBITA margin in 2024 for the top 30 global medtech companies, down from approximately 31% in 2020; the analysis used quarterly company data through August 31, 2024.[15]

08 Statistics

Regulation & Risk

Regulatory timing is central in 2026, with the U.S. Quality Management System Regulation effective on February 2, 2026 and EU IVDR transition deadlines extending to December 31, 2027 for certain class D devices.

Regulations and compliance for global medical device

  • The FDA’s Quality Management System Regulation became effective on February 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 for finished medical-device manufacturers in the United States.[7]
  • EU IVDR transition deadlines extend to December 31, 2027 for certain class D devices, December 31, 2028 for certain class C devices, and December 31, 2029 for lower-risk class B and sterile class A devices.[16]
  • All medical devices, including IVDs, custom-made devices and procedure packs, must be registered with the MHRA before placement on the Great Britain market under UK MDR 2002.[17]

Recalls and safety notices for global medical device

  • Class II recalls accounted for 88% of U.S. medical-device recalls during fiscal years 2020–2024, representing 3,468 of 3,934 recall events.[18]
  • FDA recorded 3,934 medical-device recall events initiated during fiscal years 2020–2024, covering devices regulated under the U.S. medical-device recall system.[18]
  • FDA reported 1,017 medical-device recalls in fiscal year 2024, compared with 333 biologics recalls and 318 drug recalls in the same period.[18]
  • 74% of medical-device recalls initiated during fiscal years 2020–2024 exceeded FDA’s 90-business-day termination goal after manufacturers completed corrective actions.[18]

Key questions about the global medical device industry

What is the estimated global medical device market size in 2026?
The global medical device market is estimated at $570.0 billion in 2026, up from $540.3 billion in 2025.
How fast is the global medical device market expected to grow?
The market forecast projects a 6.2% CAGR from 2025 to 2030, reaching $729.8 billion by 2030.
Which companies lead the global medical device industry?
Boston Scientific stands out for interventional cardiovascular and MedSurg reach because it reported $20.1 billion in FY2025 sales across cardiovascular and MedSurg businesses, while Medtronic focuses on global healthcare technology since it reported FY2026 revenue of $36.4 billion.
What technology shifts are being cited for growth?
Growth is being supported by intelligent, connected, minimally invasive devices, and AI-assisted technologies that reshape diagnostic and therapeutic workflows.
How is the market structured by region?
North America accounted for about 35.2% of global medical device revenue in 2025, followed by Europe at 26.2% and Asia-Pacific at 23.0%.
What regulatory change matters for U.S. device quality systems in 2026?
The FDA’s Quality Management System Regulation took effect on February 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 21). Global Medical Device Industry Statistics. Gitnux. https://gitnux.org/global-medical-device-industry-statistics
MLA
Samuel Norberg. "Global Medical Device Industry Statistics." Gitnux, 21 Nov 2026, https://gitnux.org/global-medical-device-industry-statistics.
Chicago
Samuel Norberg. 2026. "Global Medical Device Industry Statistics." Gitnux. https://gitnux.org/global-medical-device-industry-statistics.